Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial
作者
Jeffrey S. Weber,Geoff Gibney,Ryan J. Sullivan,Jeffrey A. Sosman,Craig L. Slingluff,Donald P. Lawrence,Theodore F. Logan,Lynn M. Schuchter,Suresh Nair,Leslie A. Fecher,Elizabeth I. Buchbinder,Elmer Berghorn,Mary Ruisi,George Kong,Joel Jiang,Christine E. Horak,F. Stephen Hodi